Comparing Mounjaro vs Saxagliptin
Mounjaro (tirzepatide) | Saxagliptin |
|
---|
Mounjaro (tirzepatide) | Saxagliptin |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Type 2 Diabetes. Mounjaro may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Type 2 Diabetes. Saxagliptin may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
|
|||||||||||||||
More about Mounjaro (tirzepatide) | More about Saxagliptin | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Mounjaro has an average rating of 8.5 out of 10 from a total of 1359 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 6% reported a negative effect. |
Saxagliptin has an average rating of 6.0 out of 10 from a total of 16 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 31% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Mounjaro side effects |
View all Saxagliptin side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Mounjaro prices |
View all Saxagliptin prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other tirzepatide brands include: Zepbound | Onglyza | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
120 hours |
3.1 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 414 drugs are known to interact with Mounjaro:
|
A total of 416 drugs are known to interact with Saxagliptin:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
N/A |
July 31, 2009 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Zepbound
Zepbound (tirzepatide) is an FDA-approved weekly injection for weight loss and obstructive sleep ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Levemir
Levemir (insulin detemir) is a long acting insulin used to treat diabetes in adults and children ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.